semaglutide prediabetes weight loss diabetes prevention trial for Prediabetes: A Guide to Preventing Type 2 In the REDEFINE 1 phase
Description
That finding deserves emphasis
Are pregnant or plan to become pregnant
Discontinuation rates due to adverse effects were higher in the higher-dose groups, which is an important consideration for tolerability in clinical practice
Some patients or prescribers may be tempted to accelerate this process, but doing so often leads to intolerable nausea and vomiting, potentially causing treatment discontinuation before therapeutic doses are reached
Spacing enzymes and semaglutide by several hours is unnecessary and may reduce enzyme effectiveness
It may not be responsible for those good benefits
